104 related articles for article (PubMed ID: 20061021)
1. The role of stem cell markers in multidrug resistance mediated by ABC transporters.
Tiwari AK; An X; Chen ZS
Leuk Res; 2010 Jun; 34(6):696-7. PubMed ID: 20061021
[No Abstract] [Full Text] [Related]
2. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.
Marques DS; Sandrini JZ; Boyle RT; Marins LF; Trindade GS
Leuk Res; 2010 Jun; 34(6):757-62. PubMed ID: 19969351
[TBL] [Abstract][Full Text] [Related]
3. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
[TBL] [Abstract][Full Text] [Related]
4. c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells.
Porro A; Iraci N; Soverini S; Diolaiti D; Gherardi S; Terragna C; Durante S; Valli E; Kalebic T; Bernardoni R; Perrod C; Haber M; Norris MD; Baccarani M; Martinelli G; Perini G
Mol Cancer Res; 2011 Aug; 9(8):1054-66. PubMed ID: 21693596
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.
Moreira MA; Bagni C; de Pinho MB; Mac-Cormick TM; dos Santos Mota M; Pinto-Silva FE; Daflon-Yunes N; Rumjanek VM
Leuk Res; 2014 Aug; 38(8):983-7. PubMed ID: 24996974
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug-resistant cells enriched from chronic myeloid leukemia cells by Doxorubicin possess tumor-initiating-cell properties.
Xin H; Kong Y; Jiang X; Wang K; Qin X; Miao ZH; Zhu Y; Tan W
J Pharmacol Sci; 2013; 122(4):299-304. PubMed ID: 23903006
[TBL] [Abstract][Full Text] [Related]
8. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.
Salustiano EJ; da Costa KM; Freire-de-Lima L; Mendonça-Previato L; Previato JO
J Biol Chem; 2020 May; 295(19):6457-6471. PubMed ID: 32229586
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.
Raaijmakers MH
Leukemia; 2007 Oct; 21(10):2094-102. PubMed ID: 17657220
[TBL] [Abstract][Full Text] [Related]
11. Getting to the root of the stem cell in mutated chronic myeloid leukemia.
Larson SM; Godley LA
Leuk Lymphoma; 2010 Dec; 51(12):2147-8. PubMed ID: 21133735
[No Abstract] [Full Text] [Related]
12. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
13. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.
Sukowati CH; Anfuso B; Pascut D; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931
[TBL] [Abstract][Full Text] [Related]
15. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
[TBL] [Abstract][Full Text] [Related]
16. Overcoming Multidrug Resistance in Cancer Stem Cells.
Moitra K
Biomed Res Int; 2015; 2015():635745. PubMed ID: 26649310
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer: cancer stem cells markers, drug resistance and treatment.
Kozovska Z; Gabrisova V; Kucerova L
Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789
[TBL] [Abstract][Full Text] [Related]
18. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
[TBL] [Abstract][Full Text] [Related]
19. The ABCs of cancer stem cell drug resistance.
Elliott A; Adams J; Al-Hajj M
IDrugs; 2010 Sep; 13(9):632-5. PubMed ID: 20799146
[TBL] [Abstract][Full Text] [Related]
20. MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes.
Vilanova-Costa CA; Porto HK; Pereira LC; Carvalho BP; Dos Santos WB; Silveira-Lacerda Ede P
Biol Trace Elem Res; 2015 Feb; 163(1-2):39-47. PubMed ID: 25253429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
